Ignite Creation Date:
2024-05-06 @ 12:08 AM
Last Modification Date:
2024-10-26 @ 10:45 AM
Study NCT ID:
NCT01499251
Status:
TERMINATED
Last Update Posted:
2016-05-05
First Post:
2011-12-20
Brief Title:
Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
Sponsor:
Organization:
Actelion